Eli Lilly and Company - stock earnings

LLY Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
April 30, 2024 BeforeMarket 7.6 billion 8.0 billion 8.6 billion

LLY Quarterly earnings

DateEarningsRevenue
2023Q4 2.2 billion USD 9.4 billion USD
2023Q3 -57.4 million USD 9.5 billion USD
2023Q2 1.8 billion USD 8.3 billion USD
2023Q1 1.3 billion USD 7.0 billion USD
2022Q4 1.9 billion USD 7.3 billion USD
2022Q3 1.5 billion USD 6.9 billion USD
2022Q2 952.5 million USD 6.5 billion USD
2022Q1 1.9 billion USD 7.8 billion USD
2021Q4 1.7 billion USD 8.0 billion USD
2021Q3 1.1 billion USD 6.8 billion USD
2021Q2 1.4 billion USD 6.7 billion USD
2021Q1 1.4 billion USD 6.8 billion USD
2020Q4 2.1 billion USD 7.4 billion USD
2020Q3 1.2 billion USD 5.7 billion USD
2020Q2 1.4 billion USD 5.5 billion USD
2020Q1 1.5 billion USD 5.9 billion USD
2019Q4 1.5 billion USD 6.1 billion USD
2019Q3 1.3 billion USD 5.5 billion USD
2019Q2 1.3 billion USD 5.6 billion USD
2019Q1 4.2 billion USD 5.1 billion USD
2018Q4 1.1 billion USD 6.4 billion USD
2018Q3 1.1 billion USD 6.1 billion USD
2018Q2 -259.9 million USD 6.4 billion USD
2018Q1 1.2 billion USD 5.7 billion USD
2017Q4 -1.7 billion USD 6.2 billion USD
2017Q3 555.6 million USD 5.7 billion USD
2017Q2 1.0 billion USD 5.8 billion USD
2017Q1 -110.8 million USD 5.2 billion USD
2016Q4 771.8 million USD 5.8 billion USD
2016Q3 778.0 million USD 5.2 billion USD
2016Q2 747.7 million USD 5.4 billion USD
2016Q1 440.1 million USD 4.9 billion USD
2015Q4 478.4 million USD 5.4 billion USD
2015Q3 799.7 million USD 5.0 billion USD
2015Q2 600.8 million USD 5.0 billion USD
2015Q1 529.5 million USD 4.6 billion USD
2014Q4 428.5 million USD 5.1 billion USD
2014Q3 500.6 million USD 4.9 billion USD
2014Q2 733.5 million USD 4.9 billion USD
2014Q1 727.9 million USD 4.7 billion USD
2013Q4 727.5 million USD 5.8 billion USD
2013Q3 1.2 billion USD 5.8 billion USD
2013Q2 1.2 billion USD 5.9 billion USD
2013Q1 1.5 billion USD 5.6 billion USD
2012Q4 827.2 million USD 6.0 billion USD
2012Q3 1.3 billion USD 5.4 billion USD
2012Q2 923.6 million USD 5.6 billion USD
2012Q1 1.0 billion USD 5.6 billion USD
2011Q4 858.2 million USD 6.0 billion USD
2011Q3 1.2 billion USD 6.1 billion USD
2011Q2 1.2 billion USD 6.3 billion USD
2011Q1 1.1 billion USD 5.8 billion USD
2010Q4 1.2 billion USD 6.2 billion USD
2010Q3 1.3 billion USD 5.7 billion USD
2010Q2 1.3 billion USD 5.7 billion USD
2010Q1 1.2 billion USD 5.5 billion USD
2009Q4 915.4 million USD 5.9 billion USD
2009Q3 941.8 million USD 5.6 billion USD
2009Q2 1.2 billion USD 5.3 billion USD
2009Q1 1.3 billion USD 5.0 billion USD
2008Q4 -3.6 billion USD 5.2 billion USD
2008Q3 -465.6 million USD 5.2 billion USD
2008Q2 958.8 million USD 5.2 billion USD
2008Q1 1.1 billion USD 4.8 billion USD
2007Q4 854.4 million USD 5.2 billion USD
2007Q3 926.3 million USD 4.6 billion USD
2007Q2 663.6 million USD 4.6 billion USD
2007Q1 508.7 million USD 4.2 billion USD
2006Q4 132.3 million USD 4.2 billion USD
2006Q3 873.6 million USD 3.9 billion USD
2006Q2 822.0 million USD 3.9 billion USD
2006Q1 834.8 million USD 3.7 billion USD
2005Q4 700.6 million USD 3.9 billion USD
2005Q3 794.4 million USD 3.6 billion USD
2005Q2 -252.0 million USD 3.7 billion USD
2005Q1 736.6 million USD 3.5 billion USD
2004Q4 -2.4 million USD 3.6 billion USD
2004Q3 755.2 million USD 3.3 billion USD
2004Q2 656.9 million USD 3.6 billion USD
2004Q1 400.4 million USD 3.4 billion USD
2003Q4 747.2 million USD 3.5 billion USD
2003Q3 714.4 million USD 3.1 billion USD
2003Q2 692.2 million USD 3.1 billion USD
2003Q1 407.0 million USD 2.9 billion USD
2002Q4 736.3 million USD 3.0 billion USD
2002Q3 683.9 million USD 2.8 billion USD
2002Q2 658.5 million USD 2.8 billion USD
2002Q1 629.2 million USD 2.6 billion USD
2001Q4 575.4 million USD 2.8 billion USD
2001Q3 570.1 million USD 2.9 billion USD
2001Q2 827.7 million USD 3.0 billion USD
2001Q1 806.8 million USD 2.8 billion USD
2000Q4 767.3 million USD 3.0 billion USD
2000Q3 778.8 million USD 2.8 billion USD
2000Q2 666.2 million USD 2.6 billion USD
2000Q1 845.5 million USD 2.5 billion USD
1999Q4 786.3 million USD 2.8 billion USD
1999Q3 732.6 million USD 2.6 billion USD
1999Q2 576.4 million USD 2.3 billion USD
1999Q1 625.7 million USD 2.3 billion USD
1998Q4 567.3 million USD 2.1 billion USD
1998Q3 518.2 million USD 2.6 billion USD
1998Q2 491.3 million USD 2.3 billion USD
1998Q1 521.1 million USD 2.3 billion USD
1997Q4 457.5 million USD 2.4 billion USD
1997Q3 456.9 million USD 2.2 billion USD
1997Q2 -1.7 billion USD 2.0 billion USD
1997Q1 432.6 million USD 2.0 billion USD
1996Q4 373.0 million USD 2.1 billion USD
1996Q3 415.6 million USD 1.8 billion USD
1996Q2 345.7 million USD 1.7 billion USD
1996Q1 389.2 million USD 1.8 billion USD
1995Q4 342.6 million USD 1.8 billion USD
1995Q3 1.2 billion USD 1.6 billion USD
1995Q2 327.1 million USD 1.6 billion USD
1995Q1 393.2 million USD 1.7 billion USD
1994Q4 290.1 million USD 578.7 million USD
1994Q3 318.7 million USD 1.8 billion USD
1994Q2 346.6 million USD 1.7 billion USD
1994Q1 330.7 million USD 1.6 billion USD
1993Q4 -523.6 million USD 1.8 billion USD
1993Q3 294.4 million USD 1.5 billion USD
1993Q2 346.8 million USD 1.6 billion USD
1993Q1 362.6 million USD 1.6 billion USD
1992Q4 311.2 million USD 1.7 billion USD
1992Q3 -268.5 million USD 1.5 billion USD
1992Q2 338.2 million USD 1.5 billion USD
1992Q1 442.6 million USD 1.6 billion USD
1991Q4 311.1 million USD 1.6 billion USD
1991Q3 297.5 million USD 1.3 billion USD
1991Q2 317.5 million USD 1.4 billion USD
1991Q1 388.6 million USD 1.4 billion USD
1990Q4 255.3 million USD 1.4 billion USD
1990Q3 256.8 million USD 1.3 billion USD
1990Q2 274.4 million USD 1.2 billion USD
1990Q1 340.8 million USD 1.2 billion USD
1989Q4 225.3 million USD 784.0 million USD
1989Q3 212.4 million USD 1.0 billion USD
1989Q2 217.1 million USD 1.1 billion USD
1989Q1 ? USD 1.2 billion USD
1988Q4 ? USD 1.0 billion USD
1988Q3 ? USD 940.6 million USD
1988Q2 ? USD 1.0 billion USD
1988Q1 ? USD 1.1 billion USD
1987Q4 ? USD 609.5 million USD
1987Q3 ? USD 957.7 million USD
1987Q2 ? USD 1.0 billion USD
1987Q1 ? USD 1.1 billion USD
1986Q4 ? USD 969.4 million USD
1986Q3 ? USD 883.4 million USD
1986Q2 ? USD 879.3 million USD
1986Q1 ? USD 988.3 million USD
1985Q4 ? USD 817.0 million USD
1985Q3 ? USD 787.9 million USD

LLY Yearly earnings

DateEarningsRevenue
2023 5.2 billion USD 34.1 billion USD
2022 6.2 billion USD 28.5 billion USD
2021 5.6 billion USD 28.3 billion USD
2020 6.2 billion USD 24.5 billion USD
2019 4.6 billion USD 22.3 billion USD
2018 3.2 billion USD 21.5 billion USD
2017 -204.1 million USD 22.9 billion USD
2016 2.7 billion USD 21.2 billion USD
2015 2.4 billion USD 20.0 billion USD
2014 2.4 billion USD 19.6 billion USD
2013 4.7 billion USD 23.1 billion USD
2012 4.1 billion USD 22.6 billion USD
2011 4.3 billion USD 24.3 billion USD
2010 5.1 billion USD 23.1 billion USD
2009 4.3 billion USD 21.8 billion USD
2008 -2.1 billion USD 20.4 billion USD
2007 3.0 billion USD 18.6 billion USD
2006 2.7 billion USD 15.7 billion USD
2005 2.0 billion USD 14.6 billion USD
2004 1.8 billion USD 13.9 billion USD
2003 2.6 billion USD 12.6 billion USD
2002 2.7 billion USD 11.1 billion USD
2001 2.8 billion USD 11.5 billion USD
2000 3.1 billion USD 10.9 billion USD
1999 2.7 billion USD 10.0 billion USD
1998 2.1 billion USD 9.2 billion USD
1997 -385.1 million USD 8.5 billion USD
1996 1.5 billion USD 7.3 billion USD
1995 2.3 billion USD 6.8 billion USD
1994 1.3 billion USD 5.7 billion USD
1993 480.2 million USD 6.5 billion USD
1992 708.7 million USD 6.2 billion USD
1991 1.3 billion USD 5.7 billion USD
1990 1.1 billion USD 5.2 billion USD
1989 939.5 million USD 4.2 billion USD
1988 761.0 million USD 4.1 billion USD
1987 643.7 million USD 3.6 billion USD
1986 558.2 million USD 3.7 billion USD
1985 517.6 million USD 3.3 billion USD

LLY

List: Contenders

Price: $745.69

52 week price:
367.35
800.78

Dividend Yield: 0.01%

5-year range yield:
0.01%
2.92%

Forward Dividend Yield: 0.70%

Payout Ratio: 93.69%

Payout Ratio Range:
35.56%
469.70%

Dividend Per Share: 5.20 USD

Earnings Per Share: 5.79 USD

P/E Ratio: 133.87

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 2.6 million

Ebitda: 758.9 million

Market Capitalization: 714.6 billion

Average Dividend Frequency: 4

Years Paying Dividends: 53

DGR3: 15.02%

DGR5: 13.93%

DGR10: 7.77%

DGR20: 6.15%

Links: